Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny ...

Boost your winter immunity with a diet rich in seasonal produce, warming spices and nutrient-dense foods. Start your day with ...

Where might we look for inspiration for new cancer therapies? Some researchers say the bowhead whale may offer clues.

Heartburn is common, but persistent chest discomfort or difficulty swallowing could signal serious issues. Gastroesophageal ...

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) shares are popping on Monday following the company's positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...

Study shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types.

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting plans for regulatory ...

Shares of Zymeworks and Jazz Pharmaceuticals climbed after the companies released what they called positive topline results from a late-stage trial of their treatment for certain cancers, including of ...

Researchers have developed a molecule called SU212 that could revolutionize treatment for triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease.